Beta

Brainsway ltd.BWAY.US Overview

US StockHealthcare
(No presentation for BWAY)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalInstitutionsTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

BWAY AI Insights

BWAY Overall Performance

BWAY AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

BWAY Recent Performance

-2.42%

Brainsway ltd.

-1.10%

Avg of Sector

-0.49%

S&P500

BWAY PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check BWAY's Trend

BWAY Key Information

BWAY Valuation Metrics

BWAY Profile

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Price of BWAY

BWAY FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

BWAY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.19
PE Ratio (TTM)
90.94
Forward PE
75.19
PS Ratio (TTM)
12.55
PB Ratio
8.63
Price-to-FCF
39.77
METRIC
VALUE
vs. INDUSTRY
Gross Margin
75.42%
Net Margin
14.62%
Revenue Growth (YoY)
27.33%
Profit Growth (YoY)
28.79%
3-Year Revenue Growth
34.09%
3-Year Profit Growth
37.21%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.19
PE Ratio (TTM)
90.94
Forward PE
75.19
PS Ratio (TTM)
12.55
PB Ratio
8.63
Price-to-FCF
39.77
Gross Margin
75.42%
Net Margin
14.62%
Revenue Growth (YoY)
27.33%
Profit Growth (YoY)
28.79%
3-Year Revenue Growth
34.09%
3-Year Profit Growth
37.21%
  • When is BWAY's latest earnings report released?

    The most recent financial report for Brainsway ltd. (BWAY) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating BWAY's short-term business performance and financial health. For the latest updates on BWAY's earnings releases, visit this page regularly.

  • Where does BWAY fall in the P/E River chart?

    According to historical valuation range analysis, Brainsway ltd. (BWAY)'s current price-to-earnings (P/E) ratio is 68.17, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of BWAY?

    According to the latest financial report, Brainsway ltd. (BWAY) reported an Operating Profit of 1.92M with an Operating Margin of 13.17% this period, representing a growth of 344.55% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is BWAY's revenue growth?

    In the latest financial report, Brainsway ltd. (BWAY) announced revenue of 14.55M, with a Year-Over-Year growth rate of 27.43%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does BWAY have?

    As of the end of the reporting period, Brainsway ltd. (BWAY) had total debt of 6.82M, with a debt ratio of 0.06. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does BWAY have?

    At the end of the period, Brainsway ltd. (BWAY) held Total Cash and Cash Equivalents of 67.95M, accounting for 0.6 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does BWAY go with three margins increasing?

    In the latest report, Brainsway ltd. (BWAY) achieved the “three margins increasing” benchmark, with a gross margin of 76.4%%, operating margin of 13.17%%, and net margin of 20.2%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess BWAY's profit trajectory and future growth potential.

  • Is BWAY's EPS continuing to grow?

    According to the past four quarterly reports, Brainsway ltd. (BWAY)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.08. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of BWAY?

    Brainsway ltd. (BWAY)'s Free Cash Flow (FCF) for the period is 503K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 81% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of BWAY?

    The latest valuation data shows Brainsway ltd. (BWAY) has a Price-To-Earnings (PE) ratio of 68.17 and a Price/Earnings-To-Growth (PEG) ratio of 0.05. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.